[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
IDEAYA Biosciences, Inc. Common Stock (IDYA)
IDEAYA Biosciences sees positive social media buzz and analyst ratings, with the stock price up XXXX% in the last XX hours. The company's upcoming ESMO update and potential for blockbuster drugs are driving investor interest.
About IDEAYA Biosciences, Inc. Common Stock
IDEAYA Biosciences, Inc. Common Stock (IDYA) is a healthcare sector stock focused on developing cancer therapies.
IDEAYA Biosciences, Inc. Common Stock uses the ticker $IDYA for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- IDEAYA Biosciences, Inc. Common Stock (IDYA) trading volume is up XXXXXX% from the previous week.
- IDEAYA Biosciences, Inc. Common Stock (IDYA) social dominance is up XXX% from the previous month.
- IDEAYA Biosciences, Inc. Common Stock (IDYA) creators is up XXXXXX% from the previous week.
- IDEAYA Biosciences, Inc. Common Stock (IDYA) engagements is up XXXXX% from the previous week.
- IDEAYA Biosciences, Inc. Common Stock (IDYA) mentions is up XXXXXX% from the previous week.
Price: $XXXXX #
Price 24-Hour Time-Series Raw Data
The current price increase of XXXX% in the last XX hours, coupled with positive analyst ratings and supportive social sentiment, suggests positive momentum driven by investor confidence in the company's cancer therapy pipeline.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| XXXX% | XXXX% | XXXXX% |
1-Year High: $XX on 2024-11-11
1-Year Low: $XXXXX on 2025-04-08
AltRank: XXX #
AltRank 24-Hour Time-Series Raw Data
IDEAYA Biosciences, Inc. Common Stock (IDYA) is currently AltRank #289 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXX +197
1 Month: XXX -XXX
6 Months: XXX +186
1 Year: XXX -XXX
1-Year High: XXXXX on 2025-08-29
1-Year Low: XX on 2025-01-11
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -XX
1 Month: XX -XX
6 Months: XX -XX
1 Year: XX -XX
1-Year High: XX on 2025-07-24
1-Year Low: X on 2025-06-11
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX +55%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXX +8.80%
1-Year High: XXXXXX on 2024-10-25
1-Year Low: XXX on 2025-05-10
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Week: XX +314%
1 Month: XXX -XX%
6 Months: XXXXX -XXXX%
1 Year: XXXXX +109%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2024-10-21
| Social Network | X |
|---|---|
| Mentions | XXX |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning IDEAYA Biosciences, Inc. Common Stock (IDYA) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XX +133%
1 Month: XX -XX%
6 Months: XXX +87%
1 Year: XXXXX +165%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-06-01
The most influential creators that mention IDEAYA Biosciences, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | X | XXXXXX | X | XXXXX |
| @semodough | X | XXXXXX | X | XXXXX |
| @Quantumup1 | X | XXXXX | X | XXX |
| @Andre_AGTC | X | XXXXX | X | XXX |
| @AponiaAnalytics | X | XXXXX | X | XX |
| @jeromeleonard5 | X | XXXXX | X | XX |
| @Biobeats99 | X | XXX | X | XX |
| @jasmi1112270 | X | XX | X | XX |
| @KjEverest6602 | X | X | X | XX |
| @jmli19698 | XX | X | X | XX |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% -X%
6 Months: XX% -X%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-10-16
1-Year Low: XX% on 2025-02-04
Most Supportive Themes
- Positive Outlook on Pipeline and Potential Blockbuster Drugs: (45%) Posts highlight the potential of IDEAYA's pipeline, particularly its Uveal Melanoma drug and DLL3 programs, with expectations of significant market impact.
- Analyst Ratings and Price Targets: (25%) Positive analyst ratings from Barclays and Citizens, with price targets of $XX and $XX respectively, are mentioned, indicating confidence in the stock's future performance.
Most Critical Themes
- General Market Volatility and Biotech Sector Performance: (10%) Some posts acknowledge the inherent volatility in the biotech sector and the importance of monitoring overall market trends.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXX | XX% | XXXXX | XX% | XX | X% |
| Total | XXX | XX% | XXXXX | XX% | XX | X% |
Social Dominance: XXXXXXX% #
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXXX% +0.00283%
1 Month: XXXXX% +0.0078%
6 Months: XXXXX% -XXXXXX%
1 Year: XXXXX% -XXXXXX%
1-Year High: XXXXX% on 2024-11-20
1-Year Low: XXXXXX% on 2025-09-23
Market Dominance: XXXXXXX% #
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-05-14
Market Cap: $XXXXXXXXXXXXX #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$0.56%
1 Month: $XXXXXXXXXXXXX +$10%
6 Months: $XXXXXXXXXXXXX +$59%
1 Year: $XXXXXXXXXXXXX -$8.90%
1-Year High: $XXXXXXXXXXXXX on 2024-11-11
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08
Top assets mentioned In the posts about IDEAYA Biosciences, Inc. Common Stock in the last XX hours
Amgen, Inc. (AMGN) Gilead Sciences, Inc. (GILD) Apogee Therapeutics, Inc. Common Stock (APGE) Merus N.V. Common Shares (MRUS) Gilead Sciences, Inc. (GILD) Protagonist Therapeutics, Inc (PTGX) Pfizer, Inc. (PFE) Avidity Biosciences, Inc. Common Stock (RNA) JPMorgan Chase (JPM)
Top topics mentioned In the posts about IDEAYA Biosciences, Inc. Common Stock in the last XX hours
stocks healthcare, $zlab, $amgn, gilead sciences, $apge, $mrus, $imcr, acquisition, $gild, $9688hk, $lqda, $ptgx, $evax, stocks consumer cyclical, $pfe, $rna, stocks bitcoin treasuries, jpmorgan chase, $23b, combo, $kura, $azn, investment, $prgo, $cort, $dcth, stocks technology, $agio, $akro, $rvmd, catalyst, $smmt, coins defi, $cytk, $bmrn, mkt, $jazz, $inbx, bmy, stocks financial services, stocks banks, momentum, $mdgl, $idyas, araujo, $xene, topics, united states, $bntx, meta, $ifrx, stocks consumer defensive, $kgc, $cde, $knsa, $dnli, $twst, $cgon, $llc, $arwr, $qure, $slno, 2x, multiplier, nasdaq, china, $rhhby, $rapp, $trml, novartis, $novnsw, $atr, $bbot, $cmg, $crml, $sats, alibaba group, $argx, $bgne, $fate, $axsm, $nuvl, $incy, $onc, $amrx, $bbio, $alks, coins solana ecosystem, $aclx, $adnt, $celc, $plug, stocks industrials, $aura, $400m, stocks, $52b, $sprb, $pali, atai life
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@jeromeleonard5 @NotthatkindofDr GSK4418959 / IDE275 I was kind of hoping to see FIH data on that at #ESMO25 $GSK $IDYA"
X Link @JacobPlieth 2025-10-13T14:13Z 30.8K followers, XXX engagements
"Citizens reiterated $IDYA Market Outperform/$45 $IMCR $PFE BMY Citizens JMP said: OS update is top of mind for investors because 1) it is the endpoint required for eventual full approval in MUM in the Ph3; and 2) the comparator arm includes IO which has long survival tails as a bar for the targeted therapy (darovasertib). The controversy about this data that we have been hearing is that due to the long OS tail of the IO comparator the darovasertib Ph3 may carry some risk. We remain bullish on the outcome and believe daro+crizo can provide superior OS for the following reasons: 1) ORR/DCR"
X Link @Quantumup1 2025-10-13T10:03Z 3827 followers, 4015 engagements
"Let's see how many of the XX biopharma-focused hedge funds hold these tickers. $IDYA 5/34 🔥 $JAZZ 4/34 $INBX 3/34 Access our FREE hedge fund screener & search your fav tickers"
X Link @BiopharmIQ 2025-10-12T20:36Z 27.3K followers, 2070 engagements
"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% $IDYA Darovasertib + crizotinib $JAZZ Zanidatamab $INBX Ozekibart (INBRX-109) Access our FREE Big Mover Report"
X Link @BiopharmIQ 2025-10-12T20:36Z 27.3K followers, 2097 engagements